Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Committee Votes Roundup topic
No spam. Unsubscribe anytime.
Votes at a glance: Commerce committee advances multiple measures, defers several others
Summary
On Feb. 12, 2025 the Senate Committee on Commerce and Consumer Protection (jointly where noted with HHS) recorded recommendations to pass several bills with amendments and to defer others; measures include condominium reforms, insurer climate-liability language, medical bills, cannabis and child-health protections.
The Senate Committee on Commerce and Consumer Protection recorded a series of recommendations on Feb. 12, 2025, advancing several bills with amendments and deferring others. The committee handled decision-making for measures that had been heard previously and also conducted new hearings before adopting recommendations.
Key outcomes
- SB 146 (condominiums): Committee recommended passage with amendments including mediator qualifications and early neutral evaluator language; effective date deferred to July 1, 2050. The recommendation was adopted.
- SB 147 (condominiums): Committee recommended passage with amendments clarifying small-claims accrual and associations lien rights; effective date deferred to July 1, 2050. The recommendation was adopted.
- SB 1166 (insurance): Committee recommended passage with amendments to encourage (rather than require) insurer claims against responsible parties, to add a private cause of action in specified circumstances, and to add definitions for climate-disaster-related terms; effective date deferred to July 1, 2050. The recommendation was adopted.
- SB 985 (consumer protection/gift-card fraud): Committee recommended passage with amendments and deferred the effective date to July 1, 2050; referred to Judiciary (see separate article for hearing details).
- SB 1150 (health; provider protections): Committee recommended passage as SD1 with amendments (deleting certain sections related to the Uniform Child Custody Jurisdiction and Enforcement Act) and the recommendation was adopted. Recorded roll-call included members voting both aye and no (Senator Fevella recorded a "no").
- SB 1429 (medical cannabis): Committee recommended passage with Department of Health and industry-proposed amendments; recommendation adopted.
- SB 1040 (medical debt): Committee recommended passage with a defective date; recommendation adopted.
- SB 1064 (cannabis-related amendments): Committee recommended passage with amendments that accepted Attorney General and industry changes and asked staff to realphabetize paragraphs; recommendation adopted.
- SB 463 (Kratom): Committee recommended deferral.
- SB 953 (hospitals): Committee recommended deferral.
- SB 1525 (electronic smoking devices and e-liquids): Committee recommended deferral after significant opposition from the Attorney Generals Office, Department of Taxation, Department of Health and public-health groups.
Where decisions were made on the record, committee chairs announced recommendations and recorded votes. Several measures were passed "with amendments" and a number were deferred to allow additional drafting or interagency coordination.
What happens next: Bills passed with committee recommendations will move to their next referrals in the legislative process; deferred bills will remain under committee consideration pending amendments, additional testimony, or interagency work.
Abbreviations and notes: "Defective date" in committee discussion refers to deferring the bills effective date for further consideration; several bills repeatedly used July 1, 2050 as a placeholder effective date for continued drafting.
